The World Health Care Congress 9^th Annual Life Sciences Summit convenes over 150 CEO and senior executives focused on creating strategies to compete in a continuing poor economy and increasingly difficult regulatory environment, while facing many changes to reimbursement and large numbers of patent expirations. CEOs, COOs, CROs, CMOs, Chief Innovation Officers and senior executives from leading pharmaceutical, biotech, medical device and diagnostic companies are in attendance and discuss strategies for diversification, the imperative for innovation, comparative effectiveness, personalized medicine, and emerging market strategies.

• Business model innovation – Developing a culture and environment needed to foster innovation across the organization
• Analyze the breakthrough trends and business models necessary to health care’s future and create a system to deliver better outcomes and higher quality care
• Collaboration models with players inside and outside the life sciences sector to respond to demands from the consumer, providers and payers
• How drawing upon technical expertise within the FDA, the medical community and industry, to look for new regulatory models and technical tools will help bring new treatments to patients
• Update on the FDA's Medical Device Innovation Initiative and how CDRH is advancing public health and facilitating innovation to help bring novel technologies to market

• Assess where the life science industry stands in the eyes of its stakeholders and what it needs to do as an industry to regain trust
• Customer-centric commercial models that are responsive to the needs of customers and align with growth strategies
• Ensure ACOs are encouraged to increase access to innovative devices and diagnostics, and use new technologies to improve the quality and efficiency of care

• Empowering payers, employers and consumers with optimized diagnostics for early prevention and improved disease management
• Explore opportunities in new and/or adjacent businesses and joint ventures to meet changing customer demand
• Case examples of how innovative companies are leveraging prevention priorities for commercial benefit and long-term reduction in costs - Quest's Gazelle application and mHealth offerings and Pfizer's Pain Project

• Navigate the evolving payer landscapes to ensure evidence needs of payers and other healthcare decision-makers are met
• Understand challenges in the global evaluation of pharmaceuticals and medical devices

• How innovative pharma and payer collaborations in data sharing are paving the way to determine the total cost of care and value
• Identifying evidence that matters to payers, providers and patients to improve outcomes
• Utilizing real world EMR and claims data to help payers make more informed formulary decisions